Loading...
CYduct Diagnostics, Inc.
CYDX•PNK
Healthcare
Medical - Devices
$0.25
$0.00(0.00%)

Over the past four quarters, CYduct Diagnostics, Inc. demonstrated steady revenue growth, increasing from $25352.00 in Q1 2023 to $26028.00 in Q4 2023. Operating income reached -$78163.00 in Q4 2023, maintaining a consistent -300% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$78163.00, reflecting operational efficiency. Net income rose to -$89454.00, with EPS at -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan